Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation

被引：0
|
作者：
Nihtinen, A
Volin, L
Juvonen, E
Ruutu, T
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [31] Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
    R Nakamura
    R Rodriguez
    J Palmer
    A Stein
    A Naing
    N Tsai
    K Chang
    M L Slovak
    R Bhatia
    R Spielberger
    N Kogut
    V Pullarkat
    M Kirschbaum
    S J Forman
    M R O'Donnell
    Bone Marrow Transplantation, 2007, 40 : 843 - 850
  • [32] Treosulfan in combination with fludarabine as part of conditioning treatment prior to allogeneic hematopoietic stem cell transplantation
    Ussowicz, M.
    DRUGS OF TODAY, 2020, 56 (06) : 389 - 403
  • [33] Treosulfan plus fludarabine - encouraging conditioning for allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Afram, G.
    Nahi, H.
    Liwing, J.
    Heeg, B.
    Mattsson, J.
    LeBlanc, K.
    Bjorkstrand, B.
    Gahrton, G.
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S592 - S592
  • [34] Incidence and onset of CMV infections following treosulfan based reduced-intensity conditioning and allogeneic stem cell transplantation
    Haversath, M.
    Rohde, S.
    Kundt, G.
    Wolff, D.
    Hilgendorf, I.
    Casper, J.
    Leithaeuser, M.
    Kahl, C.
    Freund, M.
    Junghanss, C.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S269 - S269
  • [35] Reduced-intensity conditioning followed by allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
    Ehninger, G.
    Platzbecker, U.
    Bornhaaeuser, M.
    ANNALS OF HEMATOLOGY, 2006, 85 : 66 - 67
  • [36] Successful Allogeneic Hematopoietic Stem Cell Transplantation in XIAP Deficiency Using Reduced-Intensity Conditioning
    Chellapandian, Deepak
    Krueger, Joerg
    Schechter, Tal
    Gassas, Adam
    Weitzman, Sheila
    Naqvi, Ahmed
    Ali, Muhammad
    PEDIATRIC BLOOD & CANCER, 2016, 63 (02) : 355 - 357
  • [37] Treosulfan in combination with fludarabine as conditioning for allogeneic stem cell transplantation in myelofibrosis
    Kragl, B.
    Heinz, F.
    Grosse-Thie, C.
    Henze, L.
    Lakner, J.
    Freitag, S.
    Wittke, C.
    Brueckner, F.
    Junghanss, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 151 - 152
  • [38] Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin
    Krejci, M.
    Brychtova, Y.
    Doubek, M.
    Tomiska, M.
    Navratil, M.
    Racil, Z.
    Dvorakova, D.
    Horky, O.
    Lengerova, M.
    Pospisilova, S.
    Mayer, J.
    NEOPLASMA, 2011, 58 (05) : 406 - 414
  • [39] Moderate Renal Function Impairment Does Not Affect Outcomes of Reduced-Intensity Conditioning with Fludarabine and Melphalan for Allogeneic Hematopoietic Stem Cell Transplantation
    de Souza, Jonas A.
    Saliba, Rima M.
    Patah, Poliana
    Rondon, Gabriela
    Ribeiro, Rachel
    Silva, Leandro de Padua
    Qazilbash, Muzaffar H.
    Hosing, Chitra
    Popat, Uday
    Efebera, Yvonne
    Champlin, Richard E.
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) : 1094 - 1099
  • [40] Reduced-intensity conditioning allogeneic stem cell transplantation for multiple myeloma
    Garcia, A
    Sureda, A
    Martino, R
    Valcarcel, D
    Brunet, S
    BONE MARROW TRANSPLANTATION, 2005, 35 : S200 - S200
12345